Ind-Swift Laboratories enters into joint venture to explore opportunities in pharmaceutical field

24 Jun 2022 Evaluate

Ind-Swift Laboratories has entered into a Joint Venture, which shall be operated through a newly incorporated entity viz MJM Remedies, where the Company shall have 75% stake and rest 25% stake shall be held by Ramesh Mehta. The new joint venture will explore the opportunities in the pharmaceutical field. MJM Remedies belongs to pharmaceutical industry.

Ind-Swift Laboratories is global manufacturer of Active Pharmaceutical Ingredients (API), Intermediates and formulations (through group collaboration).

Ind-Swift Lab. Share Price

119.20 0.00 (0.00%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.